Transcriptional regulation of galectin-10 (eosinophil Charcot-Leyden crystal protein) A GC box (-44 to -50) controls butyric acid induction of gene expression

Life Sciences

Volumn 69, Issue 2, 2001, Pages 201-212

  Dyer, Kimberly ^a,b   Rosenberg, Helene ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Charcot Leyden crystal protein; Clone 15; Eosinophils; Promoter; Transcription

Indexed keywords

GALAPTIN; GALECTIN 10; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; GENE EXPRESSION; LECTIN BINDING SITE; PROMOTER REGION; SILENCER GENE; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; BUTYRIC ACID; CARRIER PROTEINS; DNA-BINDING PROTEINS; EOSINOPHILS; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HL-60 CELLS; HUMANS; LYSOPHOSPHOLIPASE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ORGANIC CATION TRANSPORTER 1; PROMOTER REGIONS (GENETICS); REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; YY1 TRANSCRIPTION FACTOR;

EID: 0035370146     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01104-3     Document Type: Article

References (44)

1. God must love galectins; he made so many of them
2. Galectins: A family of animal beta-galactoside-binding lectins
3. Galectins: Structure and function of a large family of animal lectins
4. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily
5. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins
6. Eosinophil Charcot-Leyden crystal protein binds to beta-galactoside sugars
7. Selective recognition of man-nose by the human eosinophil Charcot-Leyden crystal protein (galectin-10): A crystallographic study at 1.8 A resolution
8. The genomic structure of the human Charcot-Leyden crystal protein gene is analogous to those of the galectin genes
9. Control of galectin gene expression
10. Ultrastructural analysis of the development of human basophils and mast cells in vitro
11. IgE-binding molecules (Mac-2/epsilon BP) expressed by human eosinophils. Implication in IgE-dependent eosinophil cytotoxicity
12. IgE-binding molecules (Mac-2/epsilon BP) expressed by human eosinophils. Implication in IgE-dependent eosinophil cytotoxicity
13. Galectin-3 expression in differentiating human myeloid cells
14. Characterization and functional dissection of the galectin-1 gene promoter
15. Cell-specific transcriptional regulation and reactivation of galectin-1 gene expression are controlled by DNA methylation of the promoter region
16. Transcriptional regulation by butyrate of mouse galectin-1 gene in embryonal carcinoma cells
17. Differential regulation of constitutive and retinoic acid-induced galectin-1 gene transcription in murine embryonal carcinoma and myoblastic cells
18. Human eosinophil Charcot-Leyden crystal protein: Cloning and characterization of a lysophospholipase gene promoter
19. Shared features of transcription: Mutational analysis of the eosinophil/basophil Charcot-Leyden crystal protein gene promoter
20. Hyperglycosylation of eosinophil ribonucleases in a promyelocytic leukemia cell line and in differentiated peripheral blood progenitor cells
21. Enhanced expression of the eosinophil-derived neurotoxin ribo-nuclease (RNS2) gene requires interaction between the promoter and intron
22. CC chemokine receptors 1 and 3 are differentially regulated by IL-5 during maturation of eosinophilic HL-60 cells
23. The "initiator" as a transcription control element
24. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes
25. DNA sequence requirements for transcriptinal initiator activity in mammalian cells
26. Inhibition of hematopoiesis by competitive binding of transcription factor PU.1
27. Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: Regulation of multiple myeloid CSF receptor promoters
28. Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBPα
29. Analysis of the modulation of transcriptional activity in myelopoiesis and leukemogenesis
30. Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation
31. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis
32. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis
33. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β/CBFβ proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells
34. The murine myeloperoxidase promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, myeloid nuclear factor 1 (MyNF1)
35. The t(8;21) fusion product, AML-1-ETO, associates with C/EBPα, inhibits C/EBPα-dependent transcription, and blocks granulocytic differentiation
36. Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: Potential role in gene transcription
37. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1
38. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties
39. Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death
40. Galectins in mouse embryogenesis
41. Involvement of galectin-3 expression in colorectal cancer progression and metastasis
42. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity
43. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation
44. Mammalian lysophospholipases